Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Importance of the inflammasome in gut-brain axis: from pathological driver to therapeutic target.
Should autologous HSCT be a first-line option in highly active MS? Commentary.
Serum metabolic profile at clinical onset as predictor of multiple sclerosis activity and progression after 5 years.
Cholesterol in Myelin: Supply Routes, Pathological Consequences, Biophysical Governance, and Future Frontiers.
Long-term organophosphate exposure leading to delayed neuropathy in a pesticide applicator: a case report.
P2X4 Drives Sex-Specific neuroprotection in autoimmune neuroinflammation.
Demyelinating disorders in women: epidemiology, immunology, and clinical implications across MS, NMOSD, and MOGAD.
E-based physical exercise in patients with multiple sclerosis and comorbidity (COMPACT): feasibility study and protocol for a randomized controlled trial.
Effects and Mechanisms of MP108 Probiotic Intervention During Pregnancy on Offspring Neurodevelopment.
Comment on "a proof-of-concept study on the relationship between lifetime estrogen exposure, menopausal transition, and neurodegeneration in women with multiple sclerosis".
ATF3/SLC31A1-Mediated Cuproptosis Contributes to Bortezomib-Induced Peripheral Neurotoxicity and Intervention by (-)-Epigallocatechin Gallate.
The Diverse Spectrum of Presumed Ocular Tuberculosis Including Optic Neuropathy in a Tuberculosis-Endemic Region: A Case Series from India.
Spinal dural arteriovenous fistula mimicking neuromyelitis optica spectrum disorder: a diagnostic pitfall.
Oligodendrocyte dysfunction contributes to motor deficits and Purkinje cell axonopathy in spinocerebellar ataxia type 1.
Multicentric prognostic observational study on biomarker profile in immunotherapy-naïve patients with highly active generalized myasthenia gravis (PROGNO-MG): a study protocol.
Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis - Authors' reply.
Literature Commentary June, 2026.
The correlation between serum markers of oxidative stress and fatigue and related factors in minimally disabled patients with relapsing-remitting multiple sclerosis.
Corrigendum to "Clinical and cognitive outcomes in Ocrelizumab-treated MS patients: Insights into the wearing-off phenomenon" [Multiple Sclerosis and Related Disorders, Volume 103, November 2025, 106689].
Comment on "Ocrelizumab modulates the IL-2 signaling pathway and associated lncRNAs in multiple sclerosis".
Meningococcal prophylaxis in neurological diseases treated with complement inhibitors: an expert consensus for Germany, Austria, and Switzerland.
The relationship between objective and subjective cognitive performance and clinical and MRI disease burden in early multiple sclerosis.
Anti-GLDN antibody-associated CIDP (nodopathy): transient IVIg response and B-cell depletion remission.
Independent associations of fatigue with cognitive function and quality of life in multiple sclerosis: a cross-sectional study.
Correlation of cerebrospinal fluid IL-6 as a marker of disease activity in patients with longitudinally extensive transverse myelitis.

Pages